A detailed history of Strs Ohio transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Strs Ohio holds 623,440 shares of BMY stock, worth $36.3 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
623,440
Previous 858,683 27.4%
Holding current value
$36.3 Million
Previous $35.7 Million 9.53%
% of portfolio
0.13%
Previous 0.14%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$39.66 - $51.75 $9.33 Million - $12.2 Million
-235,243 Reduced 27.4%
623,440 $32.3 Million
Q2 2024

Aug 05, 2024

BUY
$40.25 - $52.99 $11 Million - $14.5 Million
274,226 Added 46.92%
858,683 $35.7 Million
Q1 2024

May 13, 2024

SELL
$47.98 - $54.4 $3.09 Million - $3.5 Million
-64,335 Reduced 9.92%
584,457 $31.7 Million
Q4 2023

Jan 30, 2024

SELL
$48.48 - $57.85 $1.99 Million - $2.38 Million
-41,079 Reduced 5.95%
648,792 $33.3 Million
Q3 2023

Oct 26, 2023

SELL
$57.89 - $64.73 $2.88 Million - $3.22 Million
-49,769 Reduced 6.73%
689,871 $40 Million
Q2 2023

Jul 31, 2023

SELL
$63.71 - $70.74 $3 Million - $3.34 Million
-47,153 Reduced 5.99%
739,640 $47.3 Million
Q1 2023

Aug 02, 2023

BUY
$65.71 - $74.53 $3.1 Million - $3.51 Million
47,153 Added 6.38%
786,793 $54.5 Million
Q1 2023

Apr 27, 2023

SELL
$65.71 - $74.53 $2.22 Million - $2.51 Million
-33,720 Reduced 4.11%
786,793 $54.5 Million
Q4 2022

Jan 26, 2023

SELL
$68.48 - $81.09 $1.41 Million - $1.67 Million
-20,559 Reduced 2.44%
820,513 $59 Million
Q3 2022

Oct 27, 2022

SELL
$0.13 - $76.84 $42,076 - $24.9 Million
-323,666 Reduced 27.79%
841,072 $59.8 Million
Q2 2022

Jul 25, 2022

BUY
$72.62 - $79.98 $1.75 Million - $1.93 Million
24,159 Added 2.12%
1,164,738 $89.7 Million
Q1 2022

Apr 21, 2022

BUY
$61.48 - $73.72 $25.8 Million - $30.9 Million
419,547 Added 58.19%
1,140,579 $83.3 Million
Q4 2021

Jan 24, 2022

SELL
$53.63 - $62.52 $3.03 Million - $3.53 Million
-56,416 Reduced 7.26%
721,032 $45 Million
Q3 2021

Oct 22, 2021

SELL
$59.17 - $69.31 $4.71 Million - $5.52 Million
-79,593 Reduced 9.29%
777,448 $46 Million
Q2 2021

Jul 26, 2021

SELL
$61.91 - $67.42 $4.34 Million - $4.72 Million
-70,032 Reduced 7.55%
857,041 $57.3 Million
Q1 2021

Apr 23, 2021

SELL
$59.34 - $66.74 $10.5 Million - $11.8 Million
-177,324 Reduced 16.06%
927,073 $58.5 Million
Q4 2020

Jan 25, 2021

SELL
$57.74 - $65.43 $5.42 Million - $6.14 Million
-93,829 Reduced 7.83%
1,104,397 $68.5 Million
Q3 2020

Dec 14, 2020

SELL
$57.43 - $63.64 $3.56 Million - $3.95 Million
-62,069 Reduced 4.92%
1,198,226 $72.2 Million
Q2 2020

Jul 23, 2020

SELL
$54.82 - $64.09 $3.16 Million - $3.7 Million
-57,675 Reduced 4.38%
1,260,295 $74.1 Million
Q1 2020

Apr 23, 2020

SELL
$46.4 - $67.43 $1.96 Million - $2.85 Million
-42,251 Reduced 3.11%
1,317,970 $73.5 Million
Q4 2019

Jan 24, 2020

BUY
$49.21 - $64.19 $18.1 Million - $23.6 Million
367,525 Added 37.02%
1,360,221 $87.3 Million
Q3 2019

Oct 21, 2019

SELL
$42.77 - $50.71 $150,464 - $178,397
-3,518 Reduced 0.35%
992,696 $50.3 Million
Q2 2019

Jul 25, 2019

BUY
$44.62 - $49.34 $207,661 - $229,628
4,654 Added 0.47%
996,214 $45.2 Million
Q1 2019

Apr 19, 2019

BUY
$45.12 - $53.8 $534,175 - $636,938
11,839 Added 1.21%
991,560 $47.3 Million
Q4 2018

Jan 23, 2019

BUY
$48.76 - $63.23 $330,153 - $428,130
6,771 Added 0.7%
979,721 $50.9 Million
Q3 2018

Oct 19, 2018

SELL
$55.19 - $62.25 $4.2 Million - $4.74 Million
-76,113 Reduced 7.26%
972,950 $60.4 Million
Q2 2018

Aug 06, 2018

SELL
$50.53 - $62.98 $17.3 Million - $21.6 Million
-343,243 Reduced 24.65%
1,049,063 $58.1 Million
Q1 2018

Apr 20, 2018

SELL
$59.92 - $68.98 $2.35 Million - $2.7 Million
-39,214 Reduced 2.74%
1,392,306 $88.1 Million
Q4 2017

Jan 23, 2018

SELL
$59.94 - $65.35 $5.9 Million - $6.44 Million
-98,504 Reduced 6.44%
1,431,520 $87.7 Million
Q3 2017

Oct 23, 2017

BUY
$55.23 - $63.74 $84.5 Million - $97.5 Million
1,530,024
1,530,024 $97.5 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.